Medannex Ltd

📍 EDINBURGH, United Kingdom🗓 Founded 2009👥 12 employees💰 Last funded Dec 2015
Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Medannex Ltd?
Medannex Ltd has 1 investors on record on gritt.io and 1 late-stage investors.
When did Medannex Ltd last raise funding?
The most recent investment in Medannex Ltd recorded on gritt.io was in December 2015.
When was Medannex Ltd founded?
Medannex Ltd was founded in 2009.
What industry is Medannex Ltd in?
Medannex Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Medannex Ltd based?
Medannex Ltd is headquartered in EDINBURGH, United Kingdom.